Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Paraganglioma × copper dotatate CU-64 × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Gastrointestinal 1 Endocrine 1 CNS 1

Conditions

Pheochromocytoma 1 Paraganglioma 1 Metastatic Neuroendocrine Prostate Cancer 1 Gastro-enteropancreatic neuroendocrine tumor 1

Interventions

Specimen Handling 3 Temozolomide 2 Magnetic Resonance Spectroscopy 2 talazoparib 1 olaparib 1 lutetium Lu 177 dotatate 1 lanreotide 1 copper dotatate CU-64 1 Nivolumab 1 Lutetium-177 1 Lutetium 1 Ipilimumab 1 Contrast Media 1 CTLA-4 Antigen 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04711135 2026-02-12

NETTER-P

Advanced Accelerator Applications

Phase 2 Active not recruiting

11 enrolled 14 charts 1 FDA

CNSEndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡